150 related articles for article (PubMed ID: 1557341)
1. Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats.
Kogire M; Gomez G; Uchida T; Ishizuka J; Greeley GH; Thompson JC
Pancreas; 1992; 7(1):15-20. PubMed ID: 1557341
[TBL] [Abstract][Full Text] [Related]
2. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of pancreatic growth and gallbladder contractility by bile salts.
Gomez G; Townsend CM; Maani R; Singh P; Greeley GG; Thompson JC
Am J Surg; 1989 Jan; 157(1):20-6. PubMed ID: 2910123
[TBL] [Abstract][Full Text] [Related]
4. Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretion.
Koop I; Fellgiebel A; Koop H; Schafmayer A; Arnold R
Eur J Clin Invest; 1988 Oct; 18(5):517-23. PubMed ID: 3147905
[TBL] [Abstract][Full Text] [Related]
5. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
[TBL] [Abstract][Full Text] [Related]
6. Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts.
Gomez G; Townsend CM; Green DW; Rajaraman S; Greeley GH; Thompson JC
Am J Physiol; 1990 Jul; 259(1 Pt 1):G86-92. PubMed ID: 1695489
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.
Koop I; Dorn S; Koop H; Witzleb S; Beglinger C; Schafmayer A; Arnold R
Dig Dis Sci; 1991 Nov; 36(11):1625-32. PubMed ID: 1935502
[TBL] [Abstract][Full Text] [Related]
8. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas.
Kihara Y; Otsuki M
Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133
[TBL] [Abstract][Full Text] [Related]
9. Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.
Sakamoto C; Otsuki M; Ohki A; Yuu H; Maeda M; Yamasaki T; Baba S
Endocrinology; 1982 Feb; 110(2):398-402. PubMed ID: 6173205
[TBL] [Abstract][Full Text] [Related]
10. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydrocortisone on glucose- and cholecystokinin-induced insulin release from the isolated perfused rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Suehiro I; Nakamura T; Fujii M; Tani S; Baba S
Pancreas; 1988; 3(4):459-64. PubMed ID: 3050978
[TBL] [Abstract][Full Text] [Related]
12. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats.
Otsuki M; Nakano S; Tachibana I
Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939
[TBL] [Abstract][Full Text] [Related]
13. Necessity of hyperglycemia for effects of endogenous cholecystokinin on insulin and pancreatic exocrine secretion in conscious rats.
Shikado F; Miyasaka K; Funakoshi A; Kitani K
Jpn J Physiol; 1990; 40(3):383-91. PubMed ID: 2273636
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship.
Sandberg E; Ahrén B; Tendler D; Efendic S
Pharmacol Toxicol; 1988 Jul; 63(1):42-5. PubMed ID: 3041399
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of cholecystokinin and secretin-induced pancreatic exocrine secretion by endogenous insulin in humans.
Kim C; Kim K; Lee H; Song C; Ryu H; Hyun J
Pancreas; 1999 May; 18(4):410-4. PubMed ID: 10231848
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the release of cholecystokinin by bile salts in dogs and humans.
Gomez G; Upp JR; Lluis F; Alexander RW; Poston GJ; Greeley GH; Thompson JC
Gastroenterology; 1988 Apr; 94(4):1036-46. PubMed ID: 3345873
[TBL] [Abstract][Full Text] [Related]
17. Effects of C-terminal fragments of cholecystokinin on plasma insulin and glucagon concentrations in sheep.
Mineo H; Kamita H; Muto H; Ito M; Hyun HS; Onaga T; Yanaihara N
Res Vet Sci; 1997; 62(2):171-4. PubMed ID: 9243718
[TBL] [Abstract][Full Text] [Related]
18. Potentiating effect of CCK and secretin on rat exocrine pancreas and its cholinergic dependence.
Moriyoshi Y; Shiratori K; Watanabe S; Takeuchi T
Pancreas; 1991 Sep; 6(5):603-8. PubMed ID: 1719526
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of cholecystokinin-induced exocrine secretion by both exogenous and endogenous insulin in isolated and perfused rat pancreata.
Saito A; Williams JA; Kanno T
J Clin Invest; 1980 Apr; 65(4):777-82. PubMed ID: 6987265
[TBL] [Abstract][Full Text] [Related]
20. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
